Clinical Trial Results

Showing: All studies [change]
Condition: Alzheimer's Location: Worcester, Massachusetts 25 trials found
New Search
Filter
Trial Phase
Study Type
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
PHASE2INTERVENTIONAL Chino, California +4 more
RECRUITING
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
PHASE3INTERVENTIONAL Long Beach, California +4 more
RECRUITING
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
PHASE2INTERVENTIONAL Irvine, California +4 more
RECRUITING
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
PHASE2INTERVENTIONAL Oakland, California +4 more
RECRUITING
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
PHASE2INTERVENTIONAL Homewood, Alabama +4 more
RECRUITING
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
PHASE1, PHASE2INTERVENTIONAL Irvine, California +4 more
RECRUITING
Triage Survey for Neurology Research Eligibility
N/AOBSERVATIONAL Boston, Massachusetts +2 more
RECRUITING
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
PHASE3INTERVENTIONAL Fullerton, California +4 more
RECRUITING
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
PHASE4INTERVENTIONAL Irvine, California +4 more
RECRUITING
Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
N/AOBSERVATIONAL Belmont, Massachusetts
RECRUITING
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
PHASE3INTERVENTIONAL Homewood, Alabama +4 more
RECRUITING
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
Alzheimer's Tau Platform: Master Protocol
PHASE2INTERVENTIONAL San Francisco, California +2 more
RECRUITING
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Clinical Trial on Agitation in Alzheimer's Dementia
PHASE2INTERVENTIONAL Maitland, Florida +4 more
RECRUITING
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Dominantly Inherited Alzheimer Network (DIAN)
N/AOBSERVATIONAL Jacksonville, Florida +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type